| 000 | 01183 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513123306.0 | ||
| 264 | 0 | _c19970929 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a1064-1963 | ||
| 024 | 7 |
_a10.3109/10641969709083184 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMimran, A | |
| 245 | 0 | 0 |
_aMicroalbuminuria in essential hypertension. _h[electronic resource] |
| 260 |
_bClinical and experimental hypertension (New York, N.Y. : 1993) _c |
||
| 300 |
_a753-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlbuminuria _xdrug therapy |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aBlood Pressure _xphysiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aKidney _xphysiopathology |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tClinical and experimental hypertension (New York, N.Y. : 1993) _gvol. 19 _gno. 5-6 _gp. 753-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10641969709083184 _zAvailable from publisher's website |
| 999 |
_c9227671 _d9227671 |
||